[Penetrating atheromatous ulcer of the thoracic aorta. Treatment options]

Csaba Dzsinich1, Miklós Vaszily1, Gábor Vallus1

  • 1MH Egészségügyi Központ Szív-, Ér- és Mellkas-Sebészeti Osztály Budapest Róbert Károly krt. 44. 1133.

Orvosi Hetilap
|March 18, 2014
PubMed

Insights

Penetrating atheromatous aortic ulcers are rare but dangerous. This study shows that open, hybrid, and endovascular treatments can effectively manage this condition when diagnosed early.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Medicine
  • Aortic Diseases

Background:

  • Atherosclerosis can lead to rare but severe aortic complications.
  • Penetrating atheromatous aortic ulceration is a manifestation of atherosclerosis.
  • This condition can result in acute aortic syndrome, including dissection and rupture.

Purpose of the Study:

  • To analyze the authors' experience with penetrating atheromatous aortic ulceration.
  • To evaluate treatment outcomes for this rare aortic disease.

Main Methods:

  • Retrospective analysis of 18 patients with thoracic penetrating atheromatous aortic ulceration.
  • Patients presented with severe comorbidities.
  • Treatment strategies included open surgery, hybrid techniques, and endovascular repair (endografting).

Main Results:

  • A variety of treatment options were employed based on ulcer location.
  • One patient (1/18) experienced early mortality.
  • Two patients (2/18) had late endoleak complications successfully treated with open surgery.

Conclusions:

  • Penetrating atheromatous aortic ulceration requires timely diagnosis and management.
  • Open, hybrid, and endovascular approaches offer good outcomes for this condition.
  • Multidisciplinary treatment strategies are crucial for managing complex aortic pathologies.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444